Integrated Investment Consultants’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,342
Closed -$215K 206
2020
Q2
$215K Sell
2,342
-78
-3% -$7.48K 0.1% 148
2020
Q1
$218K Sell
2,420
-159
-6% -$16.9K 0.13% 125
2019
Q4
$293K Hold
2,579
0.12% 120
2019
Q3
$280K Buy
+2,579
New +$269K 0.14% 108
2018
Q2
Sell
-1,445
Closed -$116K 491
2018
Q1
$116K Buy
+1,445
New +$119K 0.05% 298
2017
Q3
$89K Buy
1,139
+17
+2% +$1.41K 0.04% 320
2017
Q2
$100K Hold
1,122
0.05% 292
2017
Q1
$90K Hold
1,122
0.04% 306
2016
Q4
$80K Hold
1,122
0.04% 321
2016
Q3
$93K Hold
1,122
0.05% 284
2016
Q2
$97K Buy
1,122
+225
+25% +$18.2K 0.05% 267
2016
Q1
$69K Buy
+897
New +$67.6K 0.04% 305

Other funds holding MDT

Integrated Investment Consultants's MDT Position: Q3 2020 in Review

Integrated Investment Consultants sold out of Medtronic (MDT) in Q3 2020, closing a stake of 2,342 shares — an estimated $215K sold.

Integrated Investment Consultants first reported a position in MDT in Q1 2016 and held it in 12 quarters. The position peaked at $293K in Q4 2019. 1,810 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

  • Integrated Investment Consultants reported no remaining Medtronic position as of Q3 2020 after selling out during the quarter.
  • Integrated Investment Consultants sold 2,342 Medtronic shares in Q3 2020, an estimated $215K.
  • Integrated Investment Consultants first reported a position in Medtronic in Q1 2016 and held it in 12 quarters.
  • Integrated Investment Consultants's Medtronic position peaked at $293K in Q4 2019.
  • 1,810 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on Integrated Investment Consultants's 13F filing for Q3 2020, filed 26 Oct 2020.